Stemtech : Stemtech Corporation signed a letter of intent to acquire Eevia Health Oyj in a reverse merger transaction.

Stemtech Corporation signed a letter of intent to acquire Eevia Health Oyj (NGM:EEVIA) in a reverse merger transaction on November 10, 2024. The proposal suggests that Eevia buy the Stemtech's assets (?Stemtech Assets?) and issue new shares to the Stemtech, providing that Stemtech will own c. 85% of the new outstanding shares after such a transaction. Stemtech's valuation would be approximately $40 million, and the remaining 15% of the shares would value Eevia at approximately $6-7 million. The final valuation, number of shares to be issued, and issue price are subject to negotiation and the due diligence process of both companies.